APP and Alzheimer disease: The study conducted by Mueller-Steiner where Cathepsin B was inhibited through genetic inactivation of the enzyme in mice expressing human familial Alzheimer’s disease mutant APP, resulted in increased levels of intracellular Aβ1-42, worsening plaque deposition and other Alzheimer’s disease-related pathologies.